Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2012. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in the company's Ordinary Shares, filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding insider trading activity rather than a financial performance report.
Material Changes
The filing details a specific transaction on May 2, 2012, involving Mr. S M Bicknell, a Person Discharging Managerial Responsibility. He transferred 250 Ordinary Shares into an Individual Savings Account (ISA) at a price of £14.3225 per share. The company was advised of this transaction on May 3, 2012.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly limited to the notification of the share transfer described above.
Investor Verification Points
- Verify the identity of Mr. S M Bicknell as a Person Discharging Managerial Responsibility.
- Confirm the transaction date of May 2, 2012, and the notification date of May 3, 2012.
- Validate the share price of £14.3225 per share at the time of the transfer.
- Confirm the volume of 250 Ordinary Shares transferred into an ISA.